These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with nonorgan-confined prostate cancer. Preisser F, Heinze A, S Abrams-Pompe R, Budäus L, Chun FK, Graefen M, Huland H, Tilki D. Prostate; 2022 Jun; 82(9):949-956. PubMed ID: 35344221 [Abstract] [Full Text] [Related]
3. Positive margin length and highest Gleason grade of tumor at the margin predict for biochemical recurrence after radical prostatectomy in patients with organ-confined prostate cancer. Chapin BF, Nguyen JN, Achim MF, Navai N, Williams SB, Prokhorova IN, Wang X, Tapia EMLN, Davis JW, Troncoso P. Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):221-227. PubMed ID: 29230008 [Abstract] [Full Text] [Related]
4. Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence. O'Neil LM, Walsh S, Cohen RJ, Lee S. BJU Int; 2015 Oct; 116 Suppl 3():42-8. PubMed ID: 26218868 [Abstract] [Full Text] [Related]
5. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. Savdie R, Horvath LG, Benito RP, Rasiah KK, Haynes AM, Chatfield M, Stricker PD, Turner JJ, Delprado W, Henshall SM, Sutherland RL, Kench JG. BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536 [Abstract] [Full Text] [Related]
6. Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee. Song W, Lee DH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, Kim JW, Lee S, Byun SS, Jeong CW, Kwak C, Cho JS, Ahn H, Jeon SS. J Cancer Res Clin Oncol; 2017 Nov; 143(11):2393-2400. PubMed ID: 28823006 [Abstract] [Full Text] [Related]
8. Primary Gleason grade 4 at the positive margin is associated with metastasis and death among patients with Gleason 7 prostate cancer undergoing radical prostatectomy. Viers BR, Sukov WR, Gettman MT, Rangel LJ, Bergstralh EJ, Frank I, Tollefson MK, Thompson RH, Boorjian SA, Karnes RJ. Eur Urol; 2014 Dec; 66(6):1116-24. PubMed ID: 25052213 [Abstract] [Full Text] [Related]
9. Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer. Ahyai SA, Zacharias M, Isbarn H, Steuber T, Eichelberg C, Köllermann J, Fisch M, Karakiewicz PI, Huland H, Graefen M, Chun FK. BJU Int; 2010 Aug; 106(4):478-83. PubMed ID: 20128781 [Abstract] [Full Text] [Related]
11. Positive surgical margins after radical prostatectomy: What should we care about? Pettenati C, Neuzillet Y, Radulescu C, Hervé JM, Molinié V, Lebret T. World J Urol; 2015 Dec; 33(12):1973-8. PubMed ID: 25939539 [Abstract] [Full Text] [Related]
13. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L. BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [Abstract] [Full Text] [Related]
14. The impact of the extent and location of positive surgical margins on the risk of biochemical recurrence following radical prostatectomy in men with Gleason 7 prostate cancers. Matti B, Reeves F, Prouse M, Zargar-Shoshtari K. Prostate; 2021 Dec; 81(16):1428-1434. PubMed ID: 34570379 [Abstract] [Full Text] [Related]
15. Long-term oncological outcomes of apical positive surgical margins at radical prostatectomy in the Shared Equal Access Regional Cancer Hospital cohort. Wadhwa H, Terris MK, Aronson WJ, Kane CJ, Amling CL, Cooperberg MR, Freedland SJ, Abern MR. Prostate Cancer Prostatic Dis; 2016 Dec; 19(4):423-428. PubMed ID: 27698440 [Abstract] [Full Text] [Related]
20. The impact of length and location of positive margins in predicting biochemical recurrence after robot-assisted radical prostatectomy with a minimum follow-up of 5 years. Sooriakumaran P, Ploumidis A, Nyberg T, Olsson M, Akre O, Haendler L, Egevad L, Nilsson A, Carlsson S, Jonsson M, Adding C, Hosseini A, Steineck G, Wiklund P. BJU Int; 2015 Jan; 115(1):106-13. PubMed ID: 24119144 [Abstract] [Full Text] [Related] Page: [Next] [New Search]